A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors

Summary

This study is to characterize the safety, tolerability and anti-tumor activity of AK127 as a single agent in adult subjects with advanced solid tumor malignancies.

Timeline

Start

2022-06

Primary completion

2023-06

Completion

2024-06

Drugs

Indications